Sio Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001482416

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2025 · 51 positions · Total reported value $395.15M · Top-10 concentration 59.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 61.6% · 14 new · 12 cut · 19 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -6.4% · vs SPY -8.6% · Prev Value $604.29M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.5% · vs SPY -3.6% · Latest Value $506.72M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, Sio Capital Management, LLC disclosed 51 equity positions with a combined reported value of $395.15M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 59.5% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were MMS ($50.95M), CELC ($38.85M), SNY ($26.56M). By sector, the heaviest allocations are Health Care 77.8%, Consumer Discretionary 16.4%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+1.7pp), Technology (+1.2pp) and away from Health Care (-3.2pp).

Versus the prior quarter, Sio Capital Management, LLC opened 14 new positions, trimmed 12 and fully exited 19, a turnover rate of 61.6% of positions. The portfolio's overlap with the prior quarter was 56% of names.

The largest new positions opened in Q3 2025 were CELC ($38.85M), ALKS ($20.25M), HSIC ($14.55M).

Of the 19 positions fully exited versus the prior quarter, the largest were GMED ($14.49M), NBIX ($12.66M), ANNX ($9.83M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • CELC CELCUITY INC · $38.85M
  • ALKS ALKERMES PLC · $20.25M
  • HSIC SCHEIN HENRY INC · $14.55M
  • KVUE KENVUE INC · $13.70M
  • GSK GSK PLC · $11.60M
  • HAE HAEMONETICS CORP MASS · $9.65M
  • KALV KALVISTA PHARMACEUTICALS INC · $8.33M
  • CRNX CRINETICS PHARMACEUTICALS IN · $7.28M

Fully Exited (vs previous quarter)

  • GMED GLOBUS MED INC · prev qtr: $14.49M · history
  • NBIX NEUROCRINE BIOSCIENCES INC · prev qtr: $12.66M
  • ANNX ANNEXON INC · prev qtr: $9.83M
  • IDXX IDEXX LABS INC · prev qtr: $9.65M
  • AORT ARTIVION INC · prev qtr: $4.94M
  • AVNS AVANOS MED INC · prev qtr: $3.54M
  • MRUS MERUS N V · prev qtr: $3.30M
  • INMB INMUNE BIO INC · prev qtr: $3.00M

Insider Transactions (Form 4)

Latest Sio Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sio Capital Management, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 59 positions worth $604.29M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-78021 (status: Approved), registered 2013-05-16
  • Regulatory AUM (Form ADV): $1.29B as of 2026-03-18
  • Client mix (by RAUM): pension and profit-sharing plans 53%, pooled investment vehicles 47%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: siocapital.com

Portfolio Structure

  • 59 positions · $604.29M reported value (Q2 2026)
  • Top 10 holdings = 48.6% of reported value
  • Largest position: AVR (ANTERIS TECHNOLOGIES GLOBAL COM) at 9.0%
  • Average position size: $10.24M

Sector Tilt

  • Health Care 86.6%
  • Consumer Discretionary 6.4%
  • Information Technology 3.1%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q2 2026: 16 new, 10 added, 22 reduced, 33 exited
  • 11 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 77.8%
Technology 1.2%
Other 4.6%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 557.62K $50.95M 12.89%
12.89%
Add
2 786.53K $38.85M 9.83%
9.83%
New
3 562.70K $26.56M 6.72%
6.72%
Add
4 577.75K $22.73M 5.75%
5.75%
Add
5 674.84K $20.25M 5.12%
5.12%
New
6 284.79K $18.82M 4.76%
4.76%
Hold
7 177.30K $14.88M 3.77%
3.77%
Add
8 219.21K $14.55M 3.68%
3.68%
New
9 387.60K $13.83M 3.50%
3.50%
Add
10 844.00K $13.70M 3.47%
3.47%
New
11 225.11K $12.19M 3.08%
3.08%
Hold
12 268.87K $11.60M 2.94%
2.94%
New
13 190.76K $11.57M 2.93%
2.93%
Reduce
14 198.03K $9.65M 2.44%
2.44%
New
15 1.50M $8.37M 2.12%
2.12%
Add
16 683.82K $8.33M 2.11%
2.11%
New
17 1.77M $7.98M 2.02%
2.02%
Reduce
18 174.84K $7.28M 1.84%
1.84%
New
19 514.95K $7.20M 1.82%
1.82%
Reduce
20 185.26K $5.50M 1.39%
1.39%
New
21 413.83K $5.35M 1.35%
1.35%
New
22 55.72K $5.10M 1.29%
1.29%
Reduce
23 307.18K $4.98M 1.26%
1.26%
Reduce
24 40.06K $4.90M 1.24%
1.24%
New
25 320.31K $4.83M 1.22%
1.22%
New
26 2.08M $4.42M 1.12%
1.12%
Hold
27 350.00K $4.39M 1.11%
1.11%
New
28 2.64M $3.69M 0.93%
0.93%
Reduce
29 189.20K $3.56M 0.90%
0.90%
Reduce
30 124.23K $3.38M 0.85%
0.85%
Hold
31 335.94K $3.29M 0.83%
0.83%
Hold
32 1.37M $2.99M 0.76%
0.76%
Hold
33 478.34K $2.73M 0.69%
0.69%
Hold
34 726.85K $2.59M 0.66%
0.66%
Hold
35 829.18K $2.58M 0.65%
0.65%
Reduce
36 2.36M $2.10M 0.53%
0.53%
Reduce
37 1.43M $1.86M 0.47%
0.47%
Reduce
38 130.63K $1.51M 0.38%
0.38%
New
39 1.34M $1.30M 0.33%
0.33%
Hold
40 2.32M $1.01M 0.26%
0.26%
Reduce
41 636.30K $948.09K 0.24%
0.24%
Hold
42 72.17K $917.32K 0.23%
0.23%
Hold
43 122.89K $600.93K 0.15%
0.15%
Hold
44 785.82K $549.92K 0.14%
0.14%
Hold
45 50.84K $233.86K 0.06%
0.06%
Hold
46 163.68K $201.32K 0.05%
0.05%
Hold
47 112.22K $165.53K 0.04%
0.04%
Reduce
48 10.10K $75.85K 0.02%
0.02%
Hold
49 10.94K $64.11K 0.02%
0.02%
Reduce
50 400.00K $14.44K 0.00%
0.00%
Hold

FAQ

What did Sio Capital Management, LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, Sio Capital Management, LLC reported 51 equity positions worth $395.15M in aggregate; its largest disclosed positions were MMS ($50.95M), CELC ($38.85M), SNY ($26.56M).

How large is Sio Capital Management, LLC's portfolio?

Sio Capital Management, LLC reported $395.15M of long equity holdings across 51 positions as of 2025-Q3. Top-10 holdings account for 59.5% of reported value.

What is Sio Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sio-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →